Donald L. Patrick PhD, MSPH, Laurie B. Burke RPh, MPH, Chad J. Gwaltney PhD, Nancy Kline Leidy PhD, Mona L. Martin RN, MPA, Lena Ring PhD

Similar documents
Task Force Background Donald Patrick. Appreciation to Reviewers. ISPOR PRO GRP Task Force Reports

Study Endpoint Considerations: Final PRO Guidance and Beyond

Addressing Content Validity of PRO Measures: The Unique Case of Rare Diseases

Patient-Reported Outcomes (PROs) and the Food and Drug Administration Draft Guidance. Donald L. Patrick University of Washington

Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective

Clinical Trial Endpoints from Mobile Technology: Regulatory Considerations September 29, 2016

Background to the Task Force. Introduction

Patient Reported Outcomes (PROs) Tools for Measurement of Health Related Quality of Life

Update on CDER s Drug Development Tool Qualification Program

Ken Bridges, MD Global Blood Therapeutics, South San Francisco, CA

Estimating sample size for qualitative research in clinical outcome assessment research: one size does not fit all! IP23

MEASURING PATIENT AND OBSERVER-REPORTED OUTCOMES (PROS AND OBSROS) IN RARE DISEASE CLINICAL TRIALS - EMERGING GOOD PRACTICES TASK FORCE

Sample Size Determination for Number of Patient Interviews When Developing a PRO Using Qualitative Research Based on the 2009 FDA PRO Guidance

Considerations for requiring subjects to provide a response to electronic patient-reported outcome instruments

Development of a patient-reported outcomes measure (PROM) for NASH that meets regulatory standards

Clinician-reported Outcomes (ClinROs), Concepts and Development

Testing the measurement equivalence of electronically migrated patient-reported outcome (PRO) instruments: Challenges and Solutions

Lessons learned along the path to qualification of an IBS outcome measure*

Measuring Respiratory Symptoms in Clinical Trials of COPD: Reliability and Validity of a Daily Diary APPENDIX

in alphabetical order:

Health and Quality of Life Outcomes BioMed Central

Update on the Clinical Outcome Assessment Qualification Program and COA Compendium

SAMPLE SIZE, GROUNDED THEORY, AND SATURATION IN COA DEVELOPMENT. Guidance for Industry: Sample size

Educational Program on Patient-Reported Outcomes (PROs) in Clinical Trials

Developing a Pediatric COA Measurement Strategy A Case Study in Asthma

SECOND ANNUAL PATIENT-REPORTED OUTCOME (PRO) CONSORTIUM WORKSHOP

NHC Webinar Series on Clinical Outcome Assessments. Patient-Reported Outcomes and Patient-Centered Outcomes: Is There a Difference?

QOL-CI: Development & Clinical U7lity of a Pediatric Quality of Life Instrument

Pediatrics Milestones and Meaningful Assessment Translating the Pediatrics Milestones into Assessment Items for use in the Clinical Setting

Migrating a PRO Instrument. Presented by: Serge Bodart (Biomedical Systems) and Alisandra Johnson (Bracket)

FDA s GREAT Workshop. Industry Perspective: Development Activities Towards Phase 3 Endpoints. September 19, 2012

Disclaimer. ISPOR 22 nd Annual International Meeting May 24, 2017 Boston, Massachusetts, USA

Understanding and measuring symptoms and health status in asthma COPD overlap: content validity of the EXACT and SGRQ

Assessing Consumer Responses to RRP: Experience at PMI in Developing Fit-for-Purpose Self-Report Instruments

Journal of Patient- Reported Outcomes. Colleen A. McHorney 1*, Mark E. Bensink 2, Laurie B. Burke 3, Vasily Belozeroff 2 and Chad Gwaltney 4,5

Sample size for pre-tests of questionnaires. PERNEGER, Thomas, et al. Abstract

The Origins and Promise of PROMIS Patient Reported Outcomes Measurement Information System

Fundamental Concepts for Using Diagnostic Classification Models. Section #2 NCME 2016 Training Session. NCME 2016 Training Session: Section 2

Health Economics & Decision Science (HEDS) Discussion Paper Series

Outpatient Guideline for the Diagnosis and Management of Asthma

Introducing the OWLQOL and WRSM Instruments

Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measurevhe_

VERDIN MANUSCRIPT REVIEW HISTORY REVISION NOTES FROM AUTHORS (ROUND 2)

A Comparison of Deaf/Hard of Hearing and Hearing Young Adults Responses to a Health Risk Behavior Survey

Investigator Initiated Study Proposal Form

COSMIN methodology for assessing the content validity of PROMs. User manual

Patient Reported Outcomes

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Ball State University

Research Plan And Design

Questionnaire Translation

Introduction. Activities undertaken 13/10/2015. Qualitative Data Analysis. CSHG Hotel Management School of Galicia

Qualitative Methods and Patient Reported Outcome Measures. Susan C Pitt, MD, MPHS Assistant Professor of Surgery University of Wisconsin

Thinking with the End in Mind: From COA Instrument to Endpoint

Assessing Cultural Competency from the Patient s Perspective: The CAHPS Cultural Competency (CC) Item Set

Incorporation of Imaging-Based Functional Assessment Procedures into the DICOM Standard Draft version 0.1 7/27/2011

Methodological Considerations in Using Patient Reported Measures in Dialysis Clinics. Acknowledgements

Abstract. Key words: bias, culture, Five-Factor Model, language, NEO-PI-R, NEO-PI-3, personality, South Africa

Literacy through Filmmaking: An interactive classroom activity

Table of Contents. Preface to the third edition xiii. Preface to the second edition xv. Preface to the fi rst edition xvii. List of abbreviations xix

Table of Contents. Clinical Outcome Assessments (COAs): A Conceptual Foundation

DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials

Title: Identifying work ability promoting factors for home care aides and assistant nurses

Creating a Child Self-Report Measure of Adverse Events Related to Cancer Treatment; Providing a Voice for the Child

Software as a Medical Device (SaMD)

Important Issues in Patient Reported Outcomes (PRO) Research

Introduction. 1.1 Facets of Measurement

What is a Special Interest Group (SIG)?

OBSERVER-REPORTED OUTCOMES IN CLINICAL TRIALS: CHALLENGES AND SOLUTIONS

Methodological Issues in Measuring the Development of Character

Research design. Neurodiversity. I praise you because I am fearfully and wonderfully made; your works are wonderful, I know that full well.

The Research Roadmap Checklist

Development of the Chronic Obstructive Pulmonary Disease Morning Symptom Diary (COPD-MSD)

An Approach to Outcome Measure Development: A Regulatory Perspective

Progress from the Patient-Centered Outcomes Research Institute (PCORI)

Research Questions and Survey Development

Semantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS

Work, Employment, and Industrial Relations Theory Spring 2008

Utility of an Early Case Capture Pediatric Cancer Registry

THE QUALITATIVE TRADITION: A COMPLIMENTARY PARADIGM FOR RESEARCH IN ECONOMIC EDUCATION

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company

Research Design. Source: John W. Creswell RESEARCH DESIGN. Qualitative, Quantitative, and Mixed Methods Approaches Third Edition

FDA SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED) CLINICAL SECTION CHECKLIST OFFICE OF DEVICE EVALUATION

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Veronika Williams University of Oxford, UK 07-Dec-2015

Clinical Trial Exit Interviews

TACKLING WITH REVIEWER S COMMENTS:

NCI CIRB Independent Model studies is described herein.

Hareendran et al. Health and Quality of Life Outcomes (2017) 15:224 DOI /s

FDA issues long-awaited final guidance on when a device modification requires a new 510(k)

Vaccine Acceptance in Two Middle Income Countries: The Impact of Attitudes on Vaccine Safety

TRANSLATING RESEARCH INTO PRACTICE

Issues in Clinical Measurement

HSPC/IRB Description of Research Form (For research projects involving human participants)

Quality of Life. The assessment, analysis and reporting of patient-reported outcomes. Third Edition

ANNEX A. STATEMENT OF WORK Task Authorization (TA) 22 FOR SUB CONTRACT WITH CIMVHR

Cognitive testing. Quality assurance of the survey. Ăirts Briăis Luxembourg, 13 May, 2009

Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and

Chapter 1 A Cultural Approach to Child Development

Culture & Survey Measurement. Timothy Johnson Survey Research Laboratory University of Illinois at Chicago

PATIENT REPORTED OUTCOMES

SEMINAR ON SERVICE MARKETING

Transcription:

Content Validity: Establishing and Reporting the Evidence in Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation - Good Research Practices Donald L. Patrick PhD, MSPH, Laurie B. Burke RPh, MPH, Chad J. Gwaltney PhD, Nancy Kline Leidy PhD, Mona L. Martin RN, MPA, Lena Ring PhD Elizabeth Molsen RN Liaison to ISPOR PRO Task Force Initiatives

Task Force established in March 2009. Task Force Background Donald Patrick Built on previous work of a previous Task Force: Evaluating and Documenting the Content Validity of Patient- Reported Outcome Instruments to Support Medical Product Labeling and Promotional Claims in the United States: Report of the ISPOR PRO Existing Instruments & Their Modifications Task Force(Rothman et. al., 2009). Authors represent a range of perspectives on PRO instruments: academia, government, research organization, and industry. More than 50 ISPOR members submitted written comments during 2 rounds of comments, in addition to those received orally during the Atlanta ISPOR presentation.

ISPOR PRO GRP Task Force Reports The 3 ISPOR PRO GRP reports published in 2009 were downloaded 5,964 times from April 2010 to March 2011. This is an average of166 times per month each. Content Validity of Existing Instruments Changing Modes of Administration Translation & Linguistic Validation

Appreciation to Reviewers We would like to thank all the reviewers of this paper for their time in reviewing and sending helpful comments for these papers. We addressed each suggestion individually and discussed all as group.

Content Validity: Establishing and Reporting the Evidence in Newly-Developed Patient-Reported Outcome (PRO) Instruments for Medical Product Evaluation Good Research Practices Part I: Eliciting Concepts for a New PRO Instrument Part II: Assessing Respondent Understanding

Paper 1: Eliciting Concepts Five Steps 1. Determine the context of use. 2. Develop the research protocol for qualitative concept elicitation and analysis. 3. Conduct the concept elicitation interviews and focus groups. 4. Analyze the qualitative data. 5. Document concept development and elicitation methodology and results.

Step 1: Determine the context of use Laurie Burke Develop a hypothesized disease model based on literature, experts, and patients. Name and define the concept within the context of a clinical trial end-point model. Select and define the target population including cultural\language groups.

Step 1: Determine the context of use continued Make preliminary decisions on the range of instrument content and structure. Select a theoretical approach to guide qualitative methods for content validity. Develop an hypothesized conceptual framework for the proposed instrument.

Clinical Trial Endpoint Model A diagram or description of the hierarchy of hypothesized relationships among all endpoints in a clinical trial Example: Concepts Indication: Reduce asthma exacerbations Endpoints Primary: Asthma Exacerbation Secondary FEV1 Asthma symptom score

Context of Use A comprehensive and clear statement that describes the manner and purpose of use and plans for interpretation of a clinical outcome assessment (COA) Concept measured Target claim Target population Intrinsic and extrinsic sources of heterogeneity considered Type of treatment Type of trial (endpoint model)

Figure 2: Example conceptual framework for a PRO evaluating the concept of pain quality Aching Pain quality Deep pain Dull Itchy Surface pain Numb Tingling

Step 2: Develop research protocol for concept elicitation & analysis Chad Gwaltney Define the target sample characteristics. Clinical and demographic characteristics Sample size/saturation Select the data collection method - focus groups, individual interviews, both. Determine the setting and location for data collection. Develop the interview guide Draft, pilot, revise. Not a script stimulate discussion Draft, pilot, revise.

Step 3: Conduct the concept elicitation interviews & focus groups Mona Martin Obtain IRB approval. Recruit and train sites. Recruit participants; monitor sample characteristics to assure representation. Select and train interviewers. Conduct interviews implement quality control measures. Record or videotape interviews. Transcribe and clean transcripts.

Step 4: Analyze the qualitative data Lena Ring Analyze qualitative data according to theoretical approach used. Establish preliminary coding framework; update as data are coded. Establish coding procedures and train coders. Organize data using a qualitative research software. program Assess saturation. Interpret results.

Figure 3: From coding framework to coding dictionary Hypothesized Conceptual Framework CODING FRAMEWORK CODING DICTIONARY PRO Instrument Review Target Product Profile Interview Guide Starting Structure for Organizing Codes Structure Expanded to add more concepts expressed by patients during coding process Contains all codes assigned, grouped by concept, and linked to patient language (quotes) Literature Clinical Experts All Code Assignments from transcripts Patient Interview Results

Figure 4: Example Saturation Table for Concept Elicitation Interviews (Example) Symptom Saturation Table CONCEPT CODES Shortness of Breath Difficult to Breathe Not Enough Air Gasping Shallow/Quick Breathing Wheezing Coughing Chest Tightness Chest Pain Dizziness/Lightheadedness NUMBER OF NEW CONCEPT CODES APPEARING IN EACH TRANSCRIPT GROUP % of TOTAL NEW CONCEPT CODES (Total = 10) Transcript Group Where Concept First Appeared Transcript Group 1 (N=5 transcripts) X X X X X X X Transcript Group 2 (N=4 transcripts) X X Transcript Group 3 (N=5 transcripts) X Transcript Group 4 (N=5 transcripts) 7 2 1 0 70% 20% 10% 0%

Figure 5: Example Multi-Vectored Approach to Understanding Qualitative Data Patient language Relevance of Concept Attribute to Measure Necessary Coverage (degree of importance to patient) INTERPRETATION & MEANING Presenting the relation of qualitative results to concepts, and wording items with the most meaningful language appropriate to measurement design Essential Coverage (degree of importance clinically and to measurement strategy) Variability of occurrence Degree of Difficulty to Patient Degree of Bother to Patient

Step 5: Document concept development & elicitation methodology & results Donald Patrick Provide target claims and any other context for use. Describe target population. Provide hypothesized and revised disease model and any input from content experts. Provide endpoint model. Provide conceptual framework and revisions made from preliminary to revised.

Step 5: Document concept development & elicitation methodology & results continued Provide study methods via protocols and guides. Provide summary of results, including evidence of saturation. Provide transcripts of interviews and focus group. Track origin and derivation of concepts captured in the PRO instrument. Summarize qualitative data. Provide key references.

Table 4: Documentation of Concept Elicitation

Part II: Assessing Patient Understanding Five Steps 1. Develop items based on findings from concept elicitation. 2. Design cognitive interview process for the planned context of use. 3. Conduct cognitive interviews. 4. Make decisions to revise the PRO instrument. 5. Document cognitive interview results for evaluation of content validity.

Step 1: Develop items based on findings from concept elicitation Chad Gwaltney Develop criteria for item development and evaluation. Choose concepts to measure. Select recall period and modes of administration. Draft Instructions

Step 1: Develop items based on findings from concept elicitation continued Develop items and match to response scales Assess readability Determine order and sequence

Sample item criteria The item captures the concept that is intended. The item is worded in a manner consistent with the expressions used by patients. The item represents a single concept, rather than a multidimensional concept. The content of the item is appropriate for the mode of administration

Step 2: Design cognitive interview process for the planned context of use Nancy Kline Leidy Identify population Design cognitive interview process Develop Protocol and Cognitive Interview Guide

Step 3: Conduct cognitive interviews Mona Martin o Train interviewers o Train subject to think aloud o Use verbal probes o Monitor interview quality o Record and transcribe o Prepare result summaries

Step 4: Make decisions to revise the PRO instrument Nancy Kline Leidy Employ an iterative process. Reduce ambiguity in item language. Assess saturation. Balance respondent input with principles of item construction and decisions on conceptual framework.

Step 5: Document cognitive interview results for evaluation of content validity Lena Ring Complete Item Tracking Matrix including final item, final response scale, any preliminary domain assignment, description of intent of item, and patient quotes supporting item intent.

Figure 2: Example Item Tracking Matrix

Next Steps and Manuscript Submission Donald Patrick Submission to Value in Health in June. Questions or comments, please email: donald@u.washington.edu or pro@ispor.org